-
Haemonetics Reports Q2 Adjusted Earnings per Share of $0.80
Monday, November 1, 2010 - 8:06am | 138Haemonetics Corporation (NYSE: HAE) today reported GAAP net revenues of $166.8 million, up 6%, net income of $21.3 million, up 18%, and earnings per share of $0.85, up 23%. Excluding transformation costs and contingent consideration income in fiscal 11, adjusted second quarter net income was $20.1...
-
DENTSPLY Meets, Beats on Sales - Analyst Blog
Thursday, October 28, 2010 - 8:03pm | 429Leading dental products maker DENTSPLY International (XRAY) posted third-quarter fiscal 2010 adjusted earnings per share of 45 cents, in line with the Zacks Consensus Estimate and a penny above the year-ago adjusted earnings. Adjusted earnings exclude one-time items such as restructuring and...
-
Cerus Corporation Reports Third Quarter Results: Loss of $0.10 Per Share
Thursday, October 28, 2010 - 4:14pm | 227Cerus Corporation (NASDAQ: CERS) today announced financial results for the third quarter ended September 30, 2010. Revenue for the third quarter of 2010 was $5.0 million, up from $4.8 million recognized during the third quarter of 2009. Total revenue for the first nine months of 2010 was $16.6...
-
Uroplasty Reports Financial Results; EPS $(0.05)
Wednesday, October 27, 2010 - 4:30pm | 128Uroplasty, Inc. (Nasdaq: UPI) today reported financial results for the second fiscal quarter ended September 30, 2010. Global sales grew 9% driven primarily by a 50% increase in Macroplastique product sales in the U.S. The operating loss for the fiscal second quarter ended September 30, 2010 was $...
-
Endologix Reports 30% Third Quarter 2010 Revenue Growth: Loss of $0.01 per share
Wednesday, October 27, 2010 - 4:24pm | 132Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, today announced financial results for the three and nine months ended September 30, 2010. John McDermott, Endologix President and Chief Executive Officer, said, "Our strong results were driven by the...
-
Immucor Attracting Call Buyers (BLUD)
Wednesday, October 27, 2010 - 2:57pm | 133Shares of Immucor, Inc. (NASDAQ: BLUD) are shooting higher mid-day and are currently up by 4.74%, trading at $17.68. Options traders are buying calls on the name today. A short while ago the December $20.00 call was purchased 1,500 times, on the offer, on open interest of only 211 contracts. This...
-
Immucor Spiking On Takeover Rumors (BLUD)
Wednesday, October 27, 2010 - 2:51pm | 55Immucor, Inc. (NASDAQ: BLUD) is spiking, up some 3% on reports that Dealreporter is reporting private equity interest in the company. According to the source, at least two financial sponsors may be circling Immucor. Immucor, Inc. engages in the development, manufacture, and sale of reagents and...
-
10 Health Care Stocks With Up to 30% Upside
Tuesday, October 26, 2010 - 12:53pm | 164(TheStreet) -- An analysis of highly-rated large and mid-cap health care stocks by TheStreet Ratings highlights a group of companies with increasing revenue and plenty of growth potential for investors. 10. Haemonetics Corp. Shares of Haemonetics Corp. (NYSE: HAE) of Braintree, Mass. closed at $55....
-
Jefferies & Company Raises Alcon Estimates
Friday, October 22, 2010 - 8:49am | 89Jefferies & Company is raising its estimates of Alcon, Inc. (NYSE: ACL) to reflect another solid quarter. The company said that its Hold Rating strictly reflects expectations for single-digit returns into the final merger negotiations. “We continue to view the final price tag for the minority...
-
Align Beats Expectations - Analyst Blog
Friday, October 22, 2010 - 8:33am | 693Align Technology Inc. (ALGN) reported the third quarter EPS of 25 cents, surpassing both the Zacks Consensus Estimates of 18 cents and the year-ago quarter's 13 cents. Total revenue increased 21% year over year to $95.9 million (above the company's guidance of $92.0–$95.0 million), marginally...
-
The Cooper Companies (COO) - Bull of the Day
Friday, October 22, 2010 - 3:57am | 163We initiate our coverage on The Cooper Companies (COO) with an Outperform rating and a target price of $61. The company reported earnings per share of $0.91 in the third quarter, $0.20 above the Zacks Consensus Estimate. Cooper proves to be a turnaround story based on rationalization of plants,...
-
Alcon Beats, Improves Outlook - Analyst Blog
Thursday, October 21, 2010 - 3:33pm | 524Alcon Inc. (ACL) reported third-quarter earnings of $1.84 per share, easily beating the Zacks Consensus Estimate of $1.75 and 7.6% ahead of the year-ago figure. Earnings were boosted by strong revenues. Revenues Quarterly revenues of Alcon increased 9% to $1.76 billion (including the impact...
-
Benzinga's Top Downgrades (STX, DEG, LZB, ACL)
Thursday, October 21, 2010 - 8:45am | 139Seagate Technology Plc (NYSE: STX) was downgraded by Robert W Baird from "outperform" to "neutral." STX's shares closed at $15.21 yesterday. Seagate Technology's 52-week trading range is $9.84 - $21.58. Credit Suisse downgraded Delhaize Group (NYSE: DEG) from "neutral" to "underperform." DEG's...
-
Alcon Reports "High Quality" EPS Beat
Thursday, October 21, 2010 - 7:05am | 191JP Morgan has published a research report on Alcon, Inc. (NYSE: ACL) after the company reported strong 3Q results last night. In the report, JP Morgan writes "For 2010, we are raising our EPS forecast by a penny to $7.68 and raising our organic sales growth forecast to 8.7% from 7.6%. We are...
-
Haemonetics Corp Enters Oversold Territory - Tale of the Tape
Wednesday, October 20, 2010 - 6:54pm | 109Haemonetics Corporation's (HAE) share price has entered into oversold territory with a stochastic value of 12.81. The Zacks Consensus Estimate on the company's earnings for year ending March 2011 increased by a cent over the past two months to $3.22 per share. Haemonetics is a Zacks #2 Rank (“Buy...